Close Menu
    What's Hot

    Longevity & Mortality Investor Conference 2026

    May 19, 2026

    Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    May 18, 2026

    International Life Settlement Forum 2026

    May 18, 2026
    X (Twitter) LinkedIn
    Longevity & Mortality Investor
    • Home
    • Coverage
      1. Life Insurance Capital Solutions
      2. Life Insurance
      3. Longevity and Mortality Risk Transfer
      4. Mortality
      5. Secondary Life Markets
      6. View All

      Will the US Asset Intensive Life Reinsurance Market Continue Recent Growth Spurt?

      April 22, 2026

      Daiichi Life to Reinsure Whole Life Block with Prismic Life

      April 13, 2026

      Reporting Change to Provide Regulators With More Transparency into US/Offshore Asset-Intensive Life Reinsurance Treaties

      January 28, 2026

      Capital Markets Investors Could Be About to Get a Slice of UK Life Insurance Risk

      November 26, 2025

      Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

      May 13, 2026

      US Annuity Sales Notch Tenth Consecutive $100bn+ Quarter

      May 11, 2026

      Life Settlement Secondary Market Returns to Growth but Plenty of Untapped Potential Still Remains

      April 22, 2026

      EIOPA Sets Out Views on Private Equity Ownership of Life Insurers in New Consultation Paper

      March 25, 2026

      Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      May 18, 2026

      Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

      May 13, 2026
      Just Group

      Safe Computing Pension Fund Completes Bulk Purchase Annuity Buy-In With Just Group

      May 11, 2026

      Bakkavor Pension Scheme Completes Bulk Purchase Annuity Buy-In With Rothesay

      May 5, 2026

      Pricing in the Unknown: Why Mortality Models Aren’t Ready for MCED Tests Just Yet

      April 9, 2026

      Better Understanding of Alzheimer’s Is Improving Lives if Not Actuarial Assumptions – Yet

      March 25, 2026

      Business as Usual in UK Pension Risk Transfer Market Amid Record Low Mortality in England and Wales

      March 25, 2026

      Latest CMI Model Shows Further Rise in Cohort Life Expectancy

      March 11, 2026

      LISA Files Amicus Brief Highlighting Consumer Impact of Adverse Ruling Regarding Term Life Insurance Policies

      May 18, 2026

      Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

      May 13, 2026

      Two Years On, PHL Variable Saga Approaches Conclusion

      May 13, 2026

      UK Equity Release Market Origination Slows To Begin 2026

      May 6, 2026

      Longevity & Mortality Investor Conference 2026

      May 19, 2026

      Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

      May 18, 2026

      International Life Settlement Forum 2026

      May 18, 2026

      LISA Files Amicus Brief Highlighting Consumer Impact of Adverse Ruling Regarding Term Life Insurance Policies

      May 18, 2026
    • Events
    • Latest Issues

      Editor’s Letter – Volume 2, Issue 5, May 2026

      May 13, 2026

      Editor’s Letter – Volume 2, Issue 4, April 2026

      April 9, 2026

      Editor’s Letter – Volume 2, Issue 3, March 2026

      March 11, 2026

      Editor’s Letter – Volume 2, Issue 2, February 2026

      February 11, 2026

      Editor’s Letter – Volume 2, Issue 1, January 2026

      January 14, 2026
    • Contact Us
    Newsletter
    Longevity & Mortality Investor

    Life Risk Industry Resilience Provides Confidence to Market

    Life Insurance Capital Solutions May 10, 2022By Greg Winterton
    Covid-19 Resilience
    Share
    Twitter LinkedIn Email
    n

    In public and/or more liquid markets, at the onset of the Covid-19 pandemic, it seemed like everything was correlated; public equities and government bonds all fell sharply as investors sought to liquidate amidst the initial panic. But the panic also spread to the private markets, with private equity portfolio company valuations being written down as investors had to re-model their portfolio company forecasts to adjust to the lockdown environment.

    nn

    Insurance company stock prices certainly took a hit. But in insurance circles, the big question was whether the pandemic was going to be so severe – and cause such an increase in population mortality – that it would damage the entire industry, leaving it in potential need of a government bailout akin to the one received by the banking sector during the Global Financial Crisis (GFC).

    nn

    Since the onset of the pandemic, however, there has been not one bail out or bankruptcy of a major US or UK life insurance company. Nor has there been much of a discussion about the systematic collapse of the life insurance markets.

    nn

    There are two main reasons for this. The first is that the pandemic did not trigger a u2018once in a hundred yearsu2019 event. According to medical journal The Lancet, the Covid-19 infection-fatality ratio was less than 1% for ages 59 years and below. It was 2.6% for persons of age 69, rising to 7.3% for persons aged 79. Those are arguably u2018goodu2019 odds for a life insurance company when modelling a pandemic; at those levels, insurance company mortality risk exposure should be manageable. Although the aforementioned fear factor affected all markets in February and March 2020, the realisation that Covid-19 was not a multi-sigma event came fairly quickly.

    nn

    u201cWhilst there was an initial concern within insurers over the potential size of excess claims, this subsided as emerging data showed relatively modest impacts. Around 60% of our UK clients saw no material impact in their portfolio experience in 2020, with no client experiencing deaths greater than 20% above pre-Covid-19 levelsu201d, said Mark Godson, Partner at EY. u201cAdditionally, for some firms, negative experience in their life insurance portfolios was offset by positive experience in their annuity portfolios.u201d

    nn

    The second reason is that the regulatory infrastructure of the life insurance industry proved to be robust enough to withstand the impact of the Covid-19 pandemic. Much of this infrastructure was implemented or strengthened following the global financial crisis, where governments and financial regulators around the world have sought to adjust the capital requirements of banks, insurance companies and other systemically important organisations to better withstand a multi-sigma event. In Europe, the Solvency II framework, brought into force in 2014, targeted insurance company balance sheets specifically. In the United States, Dodd Frank encompassed insurance companies. Both sets of legislation had – and still have – their critics, but Nicholas Bugler of law firm Willkie, Farr & Gallagher in London argues that whatu2019s not in doubt is that insurance company balance sheets are stronger from a resilience perspective than before the GFC.

    nn

    u201cCertainly, thatu2019s the case,u201d he said. u201cPurely from the perspective of balance sheet fortitude, the changes in the regulations have ensured that insurance company liquidity reserves are larger.u201d

    nn

    The main challenge in the life risk industry turned out to be the same main challenge in most other industries; the need to adapt to working in a lockdown-based environment. In the life settlement corner of the life risk industry, this was certainly the case.

    nn

    u201cWe saw some disruption to our interactions with some brokers, physicians and carriers in the first few months as they transitioned to remote working,u201d said Simon Erritt, Managing Director at Coventry Capital. u201cBut with the accelerated adoption of things like e-signatures, remote notarization and dedicated carrier contacts, the market is definitely operating more efficiently now than before the pandemic.u201d

    nn

    When reflecting on the importance of the life risk markets to the financial system, it is necessary to consider its resilience in the face of world events. Akin to how a devastating hurricane season is disastrous to catastrophe bond holders, a pandemic, in theory, would be similarly challenging to those holders of mortality risk. Life insurance companies provide trillions of dollarsu2019 worth of cover, and are therefore exposed, during a pandemic, to potentially billions of dollars of risk in the form of premature claims. If the underlying life insurance companies – arguably the most important counterparty in a life risk transaction, whether that be a secondary market transaction like life settlements or longevity risk transfer – fail, individual assets in a life risk investment portfolio would lose a substantial amount of their value.

    nn

    But life insurance companies didnu2019t fail. Whether thatu2019s due to the capital restrictions cushion imposed on insurance companies in the wake of the global financial crisis or whether itu2019s because, so far, Covid-19 has not been the u20181 in 100 yearsu2019 event, is unclear. Itu2019s probably a combination of the two. And there is still a chance that new, more aggressive strains of Covid-19 might emerge u2013 or, another virus or disease entirely u2013 that provides a systematic challenge to the life insurance company sector.

    nn

    Thatu2019s not to say that the past two years has been all plain sailing for the insurance industry. The Omicron variant that emerged at the end of 2021 caused yet more disruption to markets and lifestyles, and beyond life risk, property and casualty insurance companies have been hit with business interruption claims.

    nn

    For life risk, though, itu2019s not been anywhere near as bad as it could have been. And what is encouraging for the life risk industry u2013 and the investors, investment managers and service providers that make up the capital marketsu2019 participation in longevity and mortality risk investing u2013 is that, so far, systematic losses have been mitigated.

    nn

    u201cUnderstandably, many in the Life Risk industry were nervous at the outset of the pandemic,u201d said Chris Wells, Executive Director of the European Life Settlement Association. u201cSystematic failure was a real threat and capital requirements had not been truly tested in this manner before. And while the Covid-19 pandemic is not over, and the threat of future pandemics is ever present, the Life Risk industry has demonstrated the ability to withstand these exogenous pressures.u201d

    n
    2022 - May Life ILS Life Settlements Longevity Risk Mortality Risk Volume 1 Issue 1 - May 2022
    Share. Twitter LinkedIn Email

    Related Posts

    Leeds Building Society Staff Pension Scheme Completes Bulk Purchase Annuity Buy-In With Royal London

    May 18, 2026By LMI Newsdesk

    LISA Files Amicus Brief Highlighting Consumer Impact of Adverse Ruling Regarding Term Life Insurance Policies

    May 18, 2026By LMI Newsdesk

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026By Greg Winterton

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026By Dr. Jyotsna Kamble
    Latest Issue

    Too Early To Judge Impact of New Funded Reinsurance Rules on UK Pension Risk Transfer Market

    May 13, 2026

    Proprietary Reverse Mortgage Market Growth a Welcome Development for MBS Investors

    May 13, 2026

    Two Years On, PHL Variable Saga Approaches Conclusion

    May 13, 2026

    Chronic Disease Onset and Cumulative Exposure: Clinical, Prognostic and Underwriting Implications

    May 13, 2026
    Ad

    Where Longevity and Mortality Meet the Markets
    ISSN 2978-5219

    X (Twitter) LinkedIn
    Coverage
    • Life Insurance Capital Solutions
    • Life Insurance
    • Longevity and Mortality Risk Transfer
    • Mortality Risk
    • Secondary Life Markets
    More Info
    • Home
    • About Us
    • Contact Us
    • Guest Articles
    • Submit Story Idea
    Our Newsletter
    Get the latest industry news, commentary and events from the Longevity & Mortality Investor directly into your inbox. Why not sign up today?

    © 2026 Longevity & Mortality Investor. Website by Kavells.
    • Sitemap
    • Privacy Policy
    • Copyright Notice
    • Terms & Conditions

    Type above and press Enter to search. Press Esc to cancel.